Clinical Trial Update: Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating cariprazine for cognitive impairment in euthymic Bipolar I Disorder has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Cognitive Impairment

Drugs mentioned

• VRAYLAR (cariprazine)

Snippet

Sponsor: Lakshmi N Yatham | Conditions: Bipolar I Disorder, Cognitive Impairment | Phase 3 | Status: TERMINATED